These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 33161290)

  • 1. Apolipoprotein E ε4 genotype and risk of freezing of gait in Parkinson's disease.
    Kim R; Shin JH; Park S; Kim HJ; Jeon B
    Parkinsonism Relat Disord; 2020 Dec; 81():173-178. PubMed ID: 33161290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele.
    Shahid M; Kim J; Leaver K; Hendershott T; Zhu D; Cholerton B; Henderson VW; Tian L; Poston KL
    Neurobiol Dis; 2019 Jul; 127():278-286. PubMed ID: 30826425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of GBA variants on longitudinal freezing of gait progression in early Parkinson's disease.
    Yang N; Sang S; Peng T; Hu W; Wang J; Bai R; Lu H
    J Neurol; 2023 May; 270(5):2756-2764. PubMed ID: 36790548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF β-amyloid
    Kim R; Lee J; Kim HJ; Kim A; Jang M; Jeon B; Kang UJ
    Neurology; 2019 Jan; 92(1):e40-e47. PubMed ID: 30504429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations.
    Lautner R; Insel PS; Skillbäck T; Olsson B; Landén M; Frisoni GB; Herukka SK; Hampel H; Wallin A; Minthon L; Hansson O; Blennow K; Mattsson N; Zetterberg H
    Alzheimers Res Ther; 2017 Oct; 9(1):87. PubMed ID: 29061195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease.
    Ibanez L; Bahena JA; Yang C; Dube U; Farias FHG; Budde JP; Bergmann K; Brenner-Webster C; Morris JC; Perrin RJ; Cairns NJ; O'Donnell J; Álvarez I; Diez-Fairen M; Aguilar M; Miller R; Davis AA; Pastor P; Kotzbauer P; Campbell MC; Perlmutter JS; Rhinn H; Harari O; Cruchaga C; Benitez BA
    Acta Neuropathol Commun; 2020 Nov; 8(1):196. PubMed ID: 33213513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson's disease.
    Zenuni H; Bovenzi R; Bissacco J; Grillo P; Simonetta C; Mascioli D; Pieri M; Bernardini S; Sancesario GM; Stefani A; Mercuri NB; Schirinzi T
    Neurobiol Aging; 2023 Nov; 131():24-28. PubMed ID: 37572524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease.
    Bekris LM; Tsuang DW; Peskind ER; Yu CE; Montine TJ; Zhang J; Zabetian CP; Leverenz JB
    Mov Disord; 2015 Jun; 30(7):936-44. PubMed ID: 25808939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression from MCI to AD: predictive value of CSF Aβ42 is modified by APOE genotype.
    Kester MI; Verwey NA; van Elk EJ; Blankenstein MA; Scheltens P; van der Flier WM
    Neurobiol Aging; 2011 Aug; 32(8):1372-8. PubMed ID: 19748159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CSF apolipoprotein E, Abeta42 and cognition in Alzheimer's disease.
    Riemenschneider M; Schmolke M; Lautenschlager N; Vanderstichele H; Vanmechelen E; Guder WG; Kurz A
    Neurobiol Aging; 2002; 23(2):205-11. PubMed ID: 11804704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype.
    Blom ES; Giedraitis V; Zetterberg H; Fukumoto H; Blennow K; Hyman BT; Irizarry MC; Wahlund LO; Lannfelt L; Ingelsson M
    Dement Geriatr Cogn Disord; 2009; 27(5):458-64. PubMed ID: 19420940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in CSF biomarkers vary by Alzheimer disease stage and
    Babapour Mofrad R; Tijms BM; Scheltens P; Barkhof F; van der Flier WM; Sikkes SAM; Teunissen CE
    Neurology; 2020 Oct; 95(17):e2378-e2388. PubMed ID: 32788242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42.
    Prince JA; Zetterberg H; Andreasen N; Marcusson J; Blennow K
    Neurology; 2004 Jun; 62(11):2116-8. PubMed ID: 15184629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease.
    Desikan RS; McEvoy LK; Holland D; Thompson WK; Brewer JB; Aisen PS; Andreassen OA; Hyman BT; Sperling RA; Dale AM;
    AJNR Am J Neuroradiol; 2013 Mar; 34(3):505-10. PubMed ID: 22976236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association analyses of apolipoprotein E genotypes and cognitive performance in patients with Parkinson's disease.
    Zhu SG; Chen ZL; Xiao K; Wang ZW; Lu WB; Liu RP; Huang SS; Zhu JH; Zhang X; Wang JY
    Eur J Med Res; 2024 Jun; 29(1):334. PubMed ID: 38880878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease.
    Varges D; Jung K; Gawinecka J; Heinemann U; Schmitz M; von Ahsen N; Krasnianski A; Armstrong VW; Zerr I
    J Alzheimers Dis; 2011; 23(4):717-26. PubMed ID: 21157024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition.
    Head D; Bugg JM; Goate AM; Fagan AM; Mintun MA; Benzinger T; Holtzman DM; Morris JC
    Arch Neurol; 2012 May; 69(5):636-43. PubMed ID: 22232206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E Genotype Contributes to Motor Progression in Parkinson's Disease.
    Pu JL; Jin CY; Wang ZX; Fang Y; Li YL; Xue NJ; Zheng R; Lin ZH; Yan YQ; Si XL; Chen Y; Liu Y; Song Z; Yan YP; Tian J; Yin XZ; Zhang BR
    Mov Disord; 2022 Jan; 37(1):196-200. PubMed ID: 34612548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory in individuals with mild cognitive impairment in relation to APOE and CSF Abeta42.
    Thorvaldsson V; Nordlund A; Reinvang I; Blennow K; Zetterberg H; Wallin A; Johansson B
    Int Psychogeriatr; 2010 Jun; 22(4):598-606. PubMed ID: 20338079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.